ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0756

Renal Histopathology and Outcomes After Orthotopic Liver Transplantation

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • O'Hara, Alexander, Loyola University Medical Center, Chicago, Illinois, United States
  • Abourahma, Mohammed Ashraf, Loyola University Medical Center, Chicago, Illinois, United States
  • Brahmbhatt, Puja, Loyola University Medical Center, Chicago, Illinois, United States
  • Ahuja, Dinkar, Loyola University Medical Center, Chicago, Illinois, United States
  • Lee, Michelle, Loyola University Medical Center, Chicago, Illinois, United States
  • Ullah, Atta, Loyola University Medical Center, Chicago, Illinois, United States
  • Metwally, Sherif, Loyola University Medical Center, Chicago, Illinois, United States
  • Picken, Maria M., Loyola University Medical Center, Chicago, Illinois, United States
  • Cotler, Scott J, Loyola University Medical Center, Chicago, Illinois, United States
  • Vellanki, Kavitha, Loyola University Medical Center, Chicago, Illinois, United States
Background

Chronic kidney disease (CKD) commonly occurs after orthotopic liver transplant (OLT) and was classically attributed to calcineurin inhibitor (CNI) toxicity. Kidney biopsy findings with renal outcomes after OLT are not well characterized in the present literature.

Methods

Patients were identified using ICD-10 and CPT codes. Renal parenchymal disease was identified by a pathologist. Weighted averages were used to determine mean and standard deviation.

Results

918 patients underwent OLT between January 1, 2000 and December 31, 2023 at our institution. 15 kidney biopsies were performed in 14 patients, 1 patient had 2 biopsies. All patients received OLT for cirrhosis. 5 had metabolic dysfunction-associated steatohepatitis (MASH) (36%), 5 had hepatitis C (36%) (3 with active viremia), 2 had combined MASH and hepatitis C (14%) and 2 had alcohol related cirrhosis (14%). Kidney biopsy was performed for declining renal function (53%), proteinuria (40%) or both (7%). 36% of patients had focal and segmental sclerosis (FSGS), 21% had diabetic nephropathy, 14% had IgA nephropathy, 14% had acute tubular injury, 7% had acute interstitial nephritis, and 7% had membranoproliferative glomerulonephritis (MPGN). 7 had 30% or more glomerulosclerosis, 11 had interstitial expansion within 1-2 years of liver transplant. 1 had features of hepatic glomerulopathy along with mild IgA nephropathy.

Conclusion

Renal dysfunction after OLT was historically attributed to CNI toxicity. In our cohort, renal pathologies were instead due to a variety of patient-specific and immunologic phenomenon. A better understanding of underlying renal pathologies may improve renal outcomes after OLT.

Digital Object Identifier (DOI)